- Home
- TLSI vs SPCE Comparison
TLSI vs SPCE Comparison
Compare TLSI & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | SPCE |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 207.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | SPCE |
|---|---|---|
| Price | $7.08 | $3.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $11.50 | $9.22 |
| AVG Volume (30 Days) | 210.1K | ★ 6.0M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,207,000.00 | $1,661,000.00 |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | $2,656.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | N/A |
| 52 Week Low | $3.42 | $2.18 |
| 52 Week High | $7.95 | $6.74 |
Technical Indicators
Market Signals| Indicator | TLSI | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 42.58 |
| Support Level | $6.61 | $3.08 |
| Resistance Level | $7.95 | $3.33 |
| Average True Range (ATR) | 0.43 | 0.27 |
| MACD | -0.14 | -0.03 |
| Stochastic Oscillator | 24.63 | 23.66 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.